Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort
Open accessThe DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
Epilepsy is common in early childhood. In this age group it is associated with high rates of therapy-resistance, and with cognitive, motor, and behavioural comorbidity. A large number of genes, with wide ranging functions, are implicated in its aetiology, especially in those with therapy-resistant seizures. Identifying the more common single-gene epilepsies will aid in targeting resources, the prioritization of diagnostic testing and development of precision therapy. Previous studies of genetic testing in epilepsy have not been prospective and population-based. Therefore, the population-incidence of common genetic epilepsies remains unknown. The objective of this study was to describe the incidence and phenotypic spectrum of the most common single-gene epilepsies in young children, and to calculate what proportion are amenable to precision therapy. This was a prospective national epidemiological cohort study. All children presenting with epilepsy before 36 months of age were eligible. Children presenting with recurrent prolonged (>10 min) febrile seizures; febrile or afebrile status epilepticus (>30 min); or with clusters of two or more febrile or afebrile seizures within a 24-h period were also eligible. Participants were recruited from all 20 regional paediatric departments and four tertiary children’s hospitals in Scotland over a 3-year period. DNA samples were tested on a custom-designed 104-gene epilepsy panel. Detailed clinical information was systematically gathered at initial presentation and during follow-up. Clinical and genetic data were reviewed by a multidisciplinary team of clinicians and genetic scientists. The pathogenic significance of the genetic variants was assessed in accordance with the guidelines of UK Association of Clinical Genetic Science (ACGS). Of the 343 patients who met inclusion criteria, 333 completed genetic testing, and 80/333 (24%) had a diagnostic genetic finding. The overall estimated annual incidence of single-gene epilepsies in this well-defined population was 1 per 2120 live births (47.2/100 000; 95% confidence interval 36.9–57.5). PRRT2 was the most common single-gene epilepsy with an incidence of 1 per 9970 live births (10.0/100 000; 95% confidence interval 5.26–14.8) followed by SCN1A: 1 per 12 200 (8.26/100 000; 95% confidence interval 3.93–12.6); KCNQ2: 1 per 17 000 (5.89/100 000; 95% confidence interval 2.24–9.56) and SLC2A1: 1 per 24 300 (4.13/100 000; 95% confidence interval 1.07–7.19). Presentation before the age of 6 months, and presentation with afebrile focal seizures were significantly associated with genetic diagnosis. Single-gene disorders accounted for a quarter of the seizure disorders in this cohort. Genetic testing is recommended to identify children who may benefit from precision treatment and should be mainstream practice in early childhood onset epilepsy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Loss-of-function (LOF) missense or truncating variants cause Dravet syndrome, the prototypic DEE 13,27 , and also the non-DEE syndrome of Genetic Epilepsy with Febrile Seizures Plus (GEFS+) 28 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The incidence of syndromes associated with de novo genetic variants is likely to be similar around the world 13 ; whereas, recessive causes occur more frequently in populations with high rates of consanguinity 14 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
Early Identification of Refractory Epilepsy
Kwan, P., & Brodie, M. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002033420503 · Cited by 5,204
Scheffer, I. E., Berkovic, S., Capovilla, G., Connolly, M. B., French, J., Guilhoto, L., Hirsch, E., Jain, S., Mathern, G. W., Moshé, S. L., et al. (2017) · Epilepsia · doi:10.1111/epi.13709 · Cited by 5,054 · cited 1×
“The concept of the ‘developmental and epileptic encephalopathy’ (DEE) recognizes that in children presenting with early-onset epilepsy, neurodevelopmental comorbidity may be attributable to both the underlying cause and to the detrimental effects of uncontrolled epileptic activity (Scheffer et al., 2017).”
Self-citationIncidence of Epilepsy and Unprovoked Seizures in Rochester, Minnesota: 1935–1984
Hauser, W. A., Annegers, J. F., & Kurland, L. T. (1993) · Epilepsia · doi:10.1111/j.1528-1157.1993.tb02586.x · Cited by 2,073
Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies
Fiest, K. M., Sauro, K. M., Wiebe, S., Patten, S. B., Kwon, C.-S., Dykeman, J., Pringsheim, T., Lorenzetti, D. L., & Jetté, N. (2017) · Neurology · doi:10.1212/wnl.0000000000003509 · Cited by 1,902
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., Scheffer, I. E., Thiele, E. A., & Wright, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611618 · Cited by 1,711
Estimation of the burden of active and life-time epilepsy: a meta-analytic approach
Ngugi, A. K., Bottomley, C., Kleinschmidt, I., Sander, J. W., & Newton, C. R. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02481.x · Cited by 1,447 · cited 1×
“, 2017) and that 50–65 million individuals are affected worldwide (Ngugi et al., 2010; Fiest et al., 2017).”
A Potassium Channel Mutation in Neonatal Human Epilepsy
Biervert, C., Schroeder, B. C., Kubisch, C., Berkovic, S. F., Propping, P., Jentsch, T. J., & Steinlein, O. K. (1998) · Science · doi:10.1126/science.279.5349.403 · Cited by 1,073 · cited 1×
“The literature describes two distinct phenotypes associated with KCNQ2 variants: a self-limited familial neonatal seizure phenotype (Biervert et al., 1998; Singh et al., 2003) and a severe neonatal-onset developmental and epileptic encephalopathy (Weckhuysen et al.”
Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
Devinsky, O., Patel, A. D., Cross, J. H., Villanueva, V., Wirrell, E. C., Privitera, M., Greenwood, S. M., Roberts, C., Checketts, D., VanLandingham, K. E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714631 · Cited by 1,015 · cited 2×
“Cannabidiol also has efficacy in Lennox Gastaut syndrome (French et al., 2017; Devinsky et al., 2018), an epilepsy with varied aetiologies.”
Self-citationDevinsky, O., Cilio, M. R., Cross, H., Fernandez‐Ruiz, J., French, J., Hill, C., Katz, R., Di Marzo, V., Jutras‐Aswad, D., Notcutt, W. G., et al. (2014) · Epilepsia · doi:10.1111/epi.12631 · Cited by 1,000 · cited 1×
“In Dravet syndrome cannabidiol demonstrates efficacy (Devinsky et al. , 2017); however, there is no biological reason why cannabidiol should be specifically effective in this condition because it does not appear to act on sodium channels or GABA receptors (Devinsky et al. , 2014).”
Research works printed but not linked: 1
- The Broad Institute: Cambridge MA 2018. gnomAD Browser. http://gnomad.broadinstitute.org/(April 2018, date last accessed).
Cited by
Items 101–200 of 456
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy
Soldovieri, M. V., Freri, E., Ambrosino, P., Rivolta, I., Mosca, I., Binda, A., Murano, C., Ragona, F., Canafoglia, L., Vannicola, C., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105200 · Cited by 22
Schubert‐Bast, S., Kay, L., Simon, A., Wyatt, G., Holland, R., Rosenow, F., & Strzelczyk, A. (2021) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2021.108442 · Cited by 23
Demarest, S., Jeste, S., Agarwal, N. K., Arkilo, D., Asgharnejad, M., Hsiao, S., & Thibert, R. L. (2023) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2023.109173 · Cited by 24
Cavirani, B., Spagnoli, C., Caraffi, S. G., Cavalli, A., Cesaroni, C. A., Cutillo, G., GIORGIS, V. D., Frattini, D., Marchetti, G. B., Masnada, S., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021248 · Cited by 27
Downs, J. A., Jacoby, P., Specchio, N., Cross, J. H., Amin, S., Bahi‐Buisson, N., Rajaraman, R. R., Suter, B., Devinsky, O., Aimetti, A. A., et al. (2024) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2024.06.005 · Cited by 22
A critical evaluation of fenfluramine hydrochloride for the treatment of Dravet syndrome
Schoonjans, A., & Ceulemans, B. (2021) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2021.1877540 · Cited by 22
Reilly, C. J., Bjurulf, B., & Hallböök, T. (2022) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.15495 · Cited by 20
Predicting incidences of neurodevelopmental disorders
Lemke, J. R. (2020) · Brain · doi:10.1093/brain/awaa079 · Cited by 20
Late diagnoses of Dravet syndrome: How many individuals are we missing?
Silvennoinen, K., Puvirajasinghe, C., Hudgell, K., Sidhu, M. K., Custodio, H. M., Jones, W. D., Balestrini, S., & Sisodiya, S. M. (2021) · Epilepsia Open · doi:10.1002/epi4.12525 · Cited by 22
Yang, N.-D., Kanyo, R., Zhao, L., Li, J., Kang, P. W., Dou, A., White, K. M., Shi, J., Nerbonne, J. M., Kurata, H. T., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo3625 · Cited by 19
Deciphering the impact of coding and non-coding SCN1A gene variants on RNA splicing
Sparber, P. A., Sharova, M., Davydenko, K., Pyankov, D., Filatova, A. Y., & Skoblov, M. Y. (2023) · Brain · doi:10.1093/brain/awad383 · Cited by 20
Haploinsufficiency underlies the neurodevelopmental consequences of SLC6A1 variants
Silva, D. B., Trinidad, M. I., Ljungdahl, A., Revalde, J. L., Berguig, G. Y., Wallace, W., Patrick, C. S., Bomba, L., Arkin, M. R., Dong, S., et al. (2024) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2024.04.021 · Cited by 24
Jaber, D., Gitiaux, C., Blesson, S., Marguet, F., Buard, D., Salgado, M. V., Kamińska, A., Saada, J., Fallet‐Bianco, C., Martinovic, J., et al. (2020) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2020-107166 · Cited by 21
Glut1 Deficiency Syndrome: Novel Pathomechanisms, Current Concepts, and Challenges
Klepper, J. (2025) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.70044 · Cited by 26
Lee, J., Kim, Y. O., Lim, B. C., & Lee, J. (2023) · Epilepsia Open · doi:10.1002/epi4.12708 · Cited by 20
Palacios‐Ceña, D., Güeita‐Rodríguez, J., Gil‐Nagel, A., Jiménez‐Antona, C., García‐Bravo, C., Velarde‐García, J. F., Cuenca‐Zaldívar, J. N., & Aledo‐Serrano, Á. (2023) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.15712 · Cited by 20
Bastos, F., Quinodoz, M., Addor, M., Royer‐Bertrand, B., Fodstad, H., Rivolta, C., Poloni, C. B., Superti‐Furga, A., Roulet‐Perez, E., & Lebon, S. (2020) · BMC Neurology · doi:10.1186/s12883-019-1586-x · Cited by 18
Early-onset genetic epilepsies reaching adult clinics
Lewis‐Smith, D., Ellis, C. A., Helbig, I., & Thomas, R. H. (2020) · Brain · doi:10.1093/brain/awaa029 · Cited by 17
Kolosky, T., Goldstein Shipper, A., Sun, K., Tozduman, B., Bentzen, S., Moosa, A. N., & Erdemir, G. (2024) · Epilepsia Open · doi:10.1002/epi4.13007 · Cited by 17
Factors influencing the attainment of major motor milestones in CDKL5 deficiency disorder
Wong, K., Junaid, M. A., Demarest, S., Saldaris, J. M., Benke, T. A., Marsh, E. D., Downs, J. A., & Leonard, H. (2022) · European Journal of Human Genetics · doi:10.1038/s41431-022-01163-1 · Cited by 19
Clinical utility of exome sequencing in a pediatric epilepsy cohort
Graifman, J. L., Lippa, N. C., Mulhern, M., Bergner, A. L., & Sands, T. T. (2023) · Epilepsia · doi:10.1111/epi.17534 · Cited by 17
N‐of‐1 trials in epilepsy: A systematic review and lessons paving the way forward
Defelippe, V. M., Brilstra, E. H., Otte, W. M., Cross, J. H., O'Callaghan, F. J., GIORGIS, V. D., Poduri, A., Lerche, H., Sisodiya, S. M., Braun, K. P. J., et al. (2024) · Epilepsia · doi:10.1111/epi.18068 · Cited by 16
Essajee, F., Urban, M. F., Smit, L., Wilmshurst, J. M., Solomons, R., van Toorn, R., & Moosa, S. (2022) · Seizure · doi:10.1016/j.seizure.2022.09.001 · Cited by 17
Boßelmann, C. M., Borggräfe, I., Fazeli, W., Klein, K. M., Kluger, G. J., Müller‐Schlüter, K., Neubauer, B. A., von Spiczak, S., von Stülpnagel-Steinbeis, C., Weber, Y. G., et al. (2023) · Clinical Epileptology · doi:10.1007/s10309-023-00580-6 · Cited by 17
Common genes and recurrent causative variants in 957 Asian patients with pediatric epilepsy
Kim, S. H., Seo, J., Kwon, S. S., Teng, L., Won, D., Shin, S., Lee, J. S., Lee, S., Choi, J. R., & Kang, H. (2023) · Epilepsia · doi:10.1111/epi.17857 · Cited by 19
Јаnkovic, S. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1736035 · Cited by 19
Henry, O. J., Ygberg, S. E., Barbaro, M., Lesko, N., Karlsson, L., Peña‐Pérez, L., Båvner, A., Töhönen, V., Lindstrand, A., Stödberg, T., et al. (2025) · Epilepsia · doi:10.1111/epi.18403 · Cited by 19
Condon, C., Parkerson, K. A., Dandurand, A., Fei, W., Howse, C., Mayhew, M., Whyman, S., Ventola, P. E., Meskis, M. A., Sullivan, J., et al. (2025) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2025.110381 · Cited by 17
Quiroz, V., Alecu, J. E., Zubair, U., Bernardi, K., Zaman, Z., Rong, J., Tam, A., Kunta, A., Agianda, H. A. P., Battaglia, N., et al. (2025) · Brain · doi:10.1093/brain/awaf297 · Cited by 16
Falsaperla, R., Criscione, R., Cimino, C., Pisani, F., & Ruggieri, M. (2023) · Neuropediatrics · doi:10.1055/a-2060-4576 · Cited by 16
Zhu, Z., Li, Y., Xu, J., Xue, H., Feng, X., Zhu, Y.-C., & Xiong, Z. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113202 · Cited by 21
Bayat, A., Iavarone, S., Miceli, F., Jakobsen, A. V., Johannesen, K. M., Nikanorova, M., Płoski, R., Szymańska, K., Flamini, R. J., Cooper, E. C., et al. (2023) · Neurotherapeutics · doi:10.1016/j.neurot.2023.10.006 · Cited by 19
Papadopoulou, M. T., Muccioli, L., Bisulli, F., Klotz, K. A., Fons, C., Trivisano, M., Kabulashvili, T., Specchio, N., Lesca, G., & Arzimanoglou, A. A. (2024) · Epilepsia Open · doi:10.1002/epi4.12930 · Cited by 15
GIORGIS, V. D., Bhatia, K. P., Boespflug‐Tanguy, O., Gras, D., Marina, A. D., Desurkar, A., Toledo, M., Miller, I., Rotstein, M. S., Schneider, S. A., et al. (2024) · Movement Disorders · doi:10.1002/mds.29822 · Cited by 15
Symonds, J. D., Park, K., Mignot, C., Macleod, S., Armstrong, M., Ashrafian, H., Bernard, G., Brown, K. E., Brunklaus, A., Callaghan, M., et al. (2024) · Epilepsia · doi:10.1111/epi.18115 · Cited by 14
Self-citationTian, F., Cao, B., Xu, H., Zhan, L., Nan, F., Li, N., Taglialatela, M., & Gao, Z. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105860 · Cited by 15
A hyperthermic seizure unleashes a surge of spreading depolarizations in Scn1a-deficient mice
Aiba, I., Ning, Y. Y., & Noebels, J. L. (2023) · JCI Insight · doi:10.1172/jci.insight.170399 · Cited by 18
Döring, J. H., Saffari, A., Bast, T., Brockmann, K., Ehrhardt, L., Fazeli, W., Janzarik, W. G., Klabunde-Cherwon, A., Kluger, G. J., Muhle, H., et al. (2022) · Neurology Genetics · doi:10.1212/nxg.0000000000200020 · Cited by 14
Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy
Hill, S. F., Jafar‐Nejad, P., Rigo, F., & Meisler, M. H. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1282201 · Cited by 18
Miceli, F., Carotenuto, L., Barrese, V., Soldovieri, M. V., Heinzen, E. L., Mandel, A. M., Lippa, N. C., Bier, L., Goldstein, D. B., Cooper, E. C., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.01040 · Cited by 16
Reilly, C. J., Bjurulf, B., & Hallböök, T. (2024) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.15937 · Cited by 16
Rodent genetic models of neurodevelopmental disorders and epilepsy
Gonzalez‐Sulser, A. (2019) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2019.12.012 · Cited by 18
Lee, I., Chang, M.-Y., Liang, J., & Chang, T. (2020) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2020.08.014 · Cited by 16
Nine patients with KCNQ2-related neonatal seizures and functional studies of two missense variants
Chokvithaya, S., Caengprasath, N., Buasong, A., Jantasuwan, S., Santawong, K., Leela-adisorn, N., Tongkobpetch, S., Ittiwut, C., Saengow, V. E., Kamolvisit, W., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-29924-y · Cited by 14
Mochel, F., Gras, D., Luton, M., Nizou, M., Giovannini, D., Delattre, C., Aubart, M., Barth, M., Martin, A. D. S., Doummar, D., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000207296 · Cited by 14
Freeman-Jones, E., Wilson, G., Eldred, C., Mercier, A., Hendry, K., Swindler, A., Symonds, J. D., Zuberi, S. M., Dorris, L., & Brunklaus, A. (2024) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2024.10.010 · Cited by 18
Self-citationLin, C., Chou, I., & Hong, S. (2021) · Medicine · doi:10.1097/md.0000000000025277 · Cited by 14
Neuronal antibody prevalence in children with seizures under 3 years: A prospective national cohort
Symonds, J. D., Moloney, T. C., Lang, B., McLellan, A. E., O’Regan, M., Macleod, S., Jollands, A., Vincent, A. C., Kirkpatrick, M., Brunklaus, A., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010318 · Cited by 15
Self-citationUtility of genetic testing in pediatric epilepsy: Experience from a low to middle-income country
Akbar, F., Saleh, R., Kirmani, S., Chand, P., Mukhtiar, K., Jan, F., Kumar, R., & Ibrahim, S. H. (2022) · Epilepsy & Behavior Reports · doi:10.1016/j.ebr.2022.100575 · Cited by 14
Salcedo‐Pérez‐Juana, M., Palacios‐Ceña, D., San-Martín-Gómez, A., Aledo‐Serrano, Á., & Florêncio, L. L. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1285377 · Cited by 11
Bjurulf, B., Reilly, C. J., & Hallböök, T. (2023) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2023.109560 · Cited by 14
Jansson, J. S., Bjurulf, B., Dellenmark‐Blom, M., Hallböök, T., & Reilly, C. J. (2024) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2023.109603 · Cited by 14
Diagnosis and treatment recommendations for glucose transporter 1 deficiency syndrome
Zhang, M.-J., Wu, D., Yu, L.-F., Li, H., Sun, D., Liang, J., Lu, X., Luo, R., Guo, Q.-H., Jin, R., et al. (2025) · World Journal of Pediatrics · doi:10.1007/s12519-024-00864-5 · Cited by 16
Zhao, B., Liao, S., Zhong, X., Luo, Y., Hong, S., Cheng, M., Zhang, J., Li, T., & Jiang, L. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.909191 · Cited by 16
Tassinari, M., Uguagliati, B., Trazzi, S., Cerchier, C. B., Cavina, O. V., Mottolese, N., Loi, M., Candini, G., Medici, G., & Ciani, E. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106146 · Cited by 16
A tale of two cohorts: Differing outcomes in infantile‐onset focal epilepsy
Triplet, E. M., Nickels, K. C., Wong‐Kisiel, L. C., Fine, A. L., & Wirrell, E. C. (2022) · Epilepsia · doi:10.1111/epi.17181 · Cited by 14
Xu, K., Qian, W., Xu, W., Yang, W., Yang, Y., Song, Y., Li, Y., Yuan, Z., Zhang, S., Zhao, F., et al. (2025) · Seizure · doi:10.1016/j.seizure.2025.08.001 · Cited by 19
Quantitative EEG Biomarkers in the Genetic Epilepsies and Associations With Neurologic Outcomes
Galer, P. D., McKee, J. L., Ruggiero, S. M., Kaufman, M. C., Ojemann, W. K. S., Ganesan, S., Ganesan, S., Gonzalez, A. K., Cao, Q., Litt, B., et al. (2025) · Neurology · doi:10.1212/wnl.0000000000214148 · Cited by 18
Bayanova, M., Bolatov, A., Bazenova, A., Nazarova, L., Nauryzbayeva, A., Tanko, N. M., Rakhimova, S., Satvaldina, N., Samatkyzy, D., Kozhamkulov, U. A., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03346-3 · Cited by 15
Review of methods for estimating the prevalence of rare diseases
Venugopal, N., Naik, G., Jayanna, K., Mohapatra, A., Sasinowski, F. J., Kartha, R. V., & Rajasimha, H. K. (2024) · Rare Disease and Orphan Drugs Journal · doi:10.20517/rdodj.2023.39 · Cited by 13
Jonsson, H., Gaily, E. K., Stjerna, S., Joensuu, T. H., Johari, M., Lehesjoki, A., & Linnankivi, T. (2024) · Epilepsia Open · doi:10.1002/epi4.12966 · Cited by 10
The impact of developmental and epileptic encephalopathies on families: a qualitative study
Velarde‐García, J. F., Güeita‐Rodríguez, J., Jiménez‐Antona, C., García‐Bravo, C., Aledo‐Serrano, Á., Gómez-Sanchez, S. M., & Palacios‐Ceña, D. (2024) · European Journal of Pediatrics · doi:10.1007/s00431-024-05677-2 · Cited by 13
Wong, K., Junaid, M. A., Alexander, S., Olson, H. E., Pestana‐Knight, E., Rajaraman, R. R., Downs, J. A., & Leonard, H. (2024) · CNS Drugs · doi:10.1007/s40263-024-01105-z · Cited by 11
Luo, H., Xie, L., Hong, S., Li, X., Li, M., Hu, Y., Ma, J., Wu, P., Zhong, M., Cheng, M., et al. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.676616 · Cited by 12
Fowkes, R., Elwan, M., Akay, E., Mitchell, C. J., Thomas, R. H., & Lewis‐Smith, D. (2022) · Epilepsy & Behavior Reports · doi:10.1016/j.ebr.2022.100549 · Cited by 12
Developmental and epileptic encephalopathies – therapeutic consequences of genetic testing
Syrbe, S. (2022) · Medizinische Genetik · doi:10.1515/medgen-2022-2145 · Cited by 18
KCNQ2- and KCNQ3-Associated Epilepsy
Weckhuysen, S., & George, A. L. (2022) · Cambridge University Press eBooks · doi:10.1017/9781009278270 · Cited by 19
CDKL5 deficiency disorder and other infantile‐onset genetic epilepsies
Daniels, C. I., Greene, C. A., Smith, L. A., Pestana‐Knight, E., Demarest, S., Zhang, B., Benke, T. A., Poduri, A., Olson, H. E., & CDKL5 Study Group (2023) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.15747 · Cited by 14
Monni, L., Kraus, L., Wawra, M., Soares-da-Silva, P., Maier, N., Schmitz, D., Holtkamp, M., & Fidzinski, P. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15689 · Cited by 13
Lu, M., Feng, R., Zhang, C., Xiao, Y., & Yin, C. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03382-z · Cited by 14
Martin, B. E., Sands, T. T., Bier, L., Bergner, A. L., Boehme, A. K., & Lippa, N. C. (2024) · Journal of Medical Genetics · doi:10.1136/jmg-2023-109450 · Cited by 15
Niu, W., Deng, L., Mojica-Perez, S. P., Tidball, A. M., Sudyk, R., Stokes, K., & Parent, J. M. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1339345 · Cited by 13
Feeding Difficulties and Gastrostomy in Dravet Syndrome: A UK-Wide Survey and 2-Center Experience
Clayton, L. M. S., Azadi, B., Eldred, C., Wilson, G., Robinson, R. A., & Sisodiya, S. M. (2024) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000200288 · Cited by 11
Case for supporting astrocyte energetics in glucose transporter 1 deficiency syndrome
Xu, W., & Borges, K. (2024) · Epilepsia · doi:10.1111/epi.18013 · Cited by 10
Agathe, J. D. S., Monin, P., Riccardi, F., Nava, C., Arnaud, L., Mignot, C., Ville, D. M., Auvin, S., Tardieu, S., Larcher, K., et al. (2025) · European Journal of Neurology · doi:10.1111/ene.70324 · Cited by 12
Brunklaus, A., Leu, C., Gramm, M., Pérez‐Palma, E., Iqbal, S., & Lal, D. (2019) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2019.12.001 · Cited by 9
Self-citationGlucose transporter type 1 deficiency syndrome: clinical aspects, diagnosis, and treatment
Veneruzzo, G., Loos, M. A., Armeno, M. L., Alonso, C. N., & Caraballo, R. H. (2022) · Archivos Argentinos de Pediatria · doi:10.5546/aap.2022-02677.eng · Cited by 10
Proof-of-concept for a gene replacement approach to CDKL5 deficiency disorder
Benke, T. A., & Kind, P. C. (2020) · Brain · doi:10.1093/brain/awaa055 · Cited by 9
Xu, Z.-Y., Guo, H., Li, L., Zhang, M., Xia, J., Xu, Z., Qiu, J., Lu, X., Ding, X., Chen, F., et al. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2020.599044 · Cited by 10
Viglione, A., Sagona, G., Carrara, F., Amato, G. M., Totaro, V., Lupori, L., Putignano, E., Pizzorusso, T., & Mazziotti, R. M. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac164 · Cited by 12
Reilly, C. J., Bjurulf, B., & Hallböök, T. (2024) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2024.110102 · Cited by 9
Müller, Y., Lengacher, L., Friscourt, F., Quairiaux, C., Stoppini, L., Magistretti, P. J., Lengacher, S., & Finsterwald, C. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1498801 · Cited by 11
Constitutive opening of the Kv7.2 pore activation gate causes KCNQ2 -developmental encephalopathy
Nappi, M., Alberini, G., Berselli, A., Roscioni, A., Soldovieri, M. V., Servettini, I., Barrese, V., Weckhuysen, S., Chiu, A. T. G., Scheffer, I. E., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2412388121 · Cited by 13
Präzisionsmedizin für genetische Epilepsien – am Anfang des Weges?
Syrbe, S. (2021) · Clinical Epileptology · doi:10.1007/s10309-021-00409-0 · Cited by 9
Kim, S. H., Kwon, S. S., Park, M. R., Lee, H. A., Kim, J. H., Cha, J., Kim, S., Baek, S. T., Kim, S. H., Lee, J. S., et al. (2023) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2023.04.003 · Cited by 9
Liao, W., & Lee, K. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad149 · Cited by 14
Mei, D., Balestrini, S., Parrini, E., Gambardella, A., Annesi, G., GIORGIS, V. D., Gana, S., Bassi, M. T., Zucca, C., Elia, M., et al. (2024) · Journal of Medical Genetics · doi:10.1136/jmg-2024-110328 · Cited by 13
Aledo‐Serrano, Á., Mingorance, A., Villanueva, V., García-Peñas, J. J., Gil‐Nagel, A., Boronat, S., Aibar, J. Á., Barrio, S. C., Yániz, M. J., Aras, L. M., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.975034 · Cited by 9
Disparate treatment outcomes according to presence of pathogenic mutations in West syndrome
Choi, H. S., Ko, A., Kim, S. H., Lee, S., Choi, J. R., Lee, J. S., Kim, H. D., & Kang, H. (2021) · Epilepsia · doi:10.1111/epi.16924 · Cited by 9
Healthcare utilization and clinical characteristics of genetic epilepsy in electronic health records
Boßelmann, C. M., Ivaniuk, A., John, M. S., Taylor, S. C., Krishnaswamy, G., Milinovich, A., Leu, C., Gupta, A., Pestana‐Knight, E., Najm, I., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae090 · Cited by 7
Approved Steroidal Drugs (2000–2025): A Medicinal Chemistry Perspective
Zhu, J., Luo, G., & Xiang, H. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03005 · Cited by 10
Aledo‐Serrano, Á., Sánchez-Alcudia, R., Toledano, R., García‐Morales, I., Beltrán‐Corbellini, Á., del Pino, I., & Gil‐Nagel, A. (2021) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2021.40 · Cited by 13
Epilepsy Genetics: Advancements in the Field and Impact on Clinical Practice
Hunter, S. E., Jalazo, E., Felton, T., Heinzen, E. L., & Shiloh‐Malawsky, Y. (2022) · Epilepsy · doi:10.36255/exon-publications-epilepsy-genetics · Cited by 12
McTague, A., Brunklaus, A., Barcia, G., Varadkar, S., Zuberi, S. M., Chatron, N., Parrini, E., Mei, D., Nabbout, R., & Lesca, G. (2022) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2022.104531 · Cited by 8
Self-citationDravet syndrome—toward an optimal and disease-specific treatment
Schoonjans, A., & Ceulemans, B. (2021) · Clinical Epileptology · doi:10.1007/s10309-021-00399-z · Cited by 9
McKeon, G., Palmer, E. E., Macintosh, R., Nevin, S. M., Wheatley, L., & Rosenbaum, S. (2021) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2021.108022 · Cited by 7
Case report: Dravet syndrome, feeding difficulties and gastrostomy
Clayton, L. M. S., Williams, E., Balestrini, S., & Sisodiya, S. M. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.993906 · Cited by 8
Saldaris, J. M., Jacoby, P. A., Marsh, E. D., Suter, B., Leonard, H., Olson, H. E., Rajaraman, R. R., Pestana‐Knight, E., Weisenberg, J. L. Z., Price, D., et al. (2024) · Epilepsy Research · doi:10.1016/j.eplepsyres.2024.107287 · Cited by 7
Scorrano, G., Dono, F., Corniello, C., Evangelista, G., Chiarelli, F., & Sensi, S. L. (2024) · Seizure · doi:10.1016/j.seizure.2024.04.019 · Cited by 7
Genetic testing, another important tool in presurgical evaluation of focal epilepsies in childhood
García-Uzquiano, R., Barcia, G., Losito, E., Chémaly, N., Kamińska, A., Desguerre, I., Blauwblomme, T., Boddaert, N., & Nabbout, R. (2024) · Epilepsia Open · doi:10.1002/epi4.12964 · Cited by 6
Metadata
- Authors
- Symonds, J. D., Zuberi, S. M., Stewart, K., McLellan, A., O‘Regan, M., MacLeod, S., Jollands, A., Joss, S., Kirkpatrick, M., Brunklaus, A., Pilz, D. T., Shetty, J., Dorris, L., Abu-Arafeh, I., Andrew, J., Brink, P., Callaghan, M., Cruden, J., Diver, L. A., Findlay, C., Gardiner, S., Grattan, R., Lang, B., MacDonnell, J., McKnight, J., Morrison, C. A., Nairn, L., Slean, M. M., Stephen, E., Webb, A., Vincent, A., & Wilson, M.
- Affiliations
- Royal Hospital for Children (GB)
- Queen Elizabeth University Hospital (GB)
- Paediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, UK
- NHS Tayside (GB)
- Department of Paediatrics, Forth Valley Royal Hospital, Larbert, UK
- Wishaw General Hospital (GB)
- Victoria Hospital (GB)
- University Hospital Crosshouse (GB)
- Forth Valley Royal Hospital (GB)
- John Radcliffe Hospital (GB)
- Borders General Hospital (GB)
- Dumfries and Galloway Royal Infirmary (GB)
- Royal Alexandra Hospital (GB)
- University of Glasgow (GB)
- Royal Aberdeen Children's Hospital (GB)
- Raigmore Hospital (GB)
- Corresponding author
- Zuberi, Sameer M
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-07-13
- Volume
- 142
- Issue
- 8
- Pages
- 2303-2318
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC6658850
- OpenAlex
- W2961503558
- Cited by
- 459
- References
- 81
- Citations by year
- 2026: 49 · 2025: 82 · 2024: 87 · 2023: 67 · 2022: 76 · 2021: 44 · 2020: 48 · 2019: 6
- FWCI
- 34.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Brain (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion, cc-by-nc)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Epilepsy Research UK
- Dravet Syndrome UK
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Keywords
- childhood-onset epilepsy, genetic epilepsy, incidence, phenotypic spectrum, PRRT2, SCN1A, KCNQ2, KCNQ3, KCNA2, KCNA1, Kv1.3 potassium channel, Kv1.5, KC
- MeSH terms
- Child, Preschool, Epilepsy, Female, Humans, Infant, Infant, Newborn, Male, Phenotype, Prospective Studies, Scotland, Cohort Studies, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.